Review



auroc analysis  (MedCalc Software Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MedCalc Software Ltd auroc analysis
    <t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
    Auroc Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pmc11795793-91-2-20?v=MedCalc+Software+Ltd
    Average 90 stars, based on 1 article reviews
    auroc analysis - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Role of C5aR2 in prognosis of patients with acute respiratory distress syndrome through negative modulation of C5a: A prospective observational study"

    Article Title: Role of C5aR2 in prognosis of patients with acute respiratory distress syndrome through negative modulation of C5a: A prospective observational study

    Journal: Heliyon

    doi: 10.1016/j.heliyon.2025.e42146

    Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
    Figure Legend Snippet: Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).

    Techniques Used:



    Similar Products

    receiver operator characteristics curve auroc analysis  (Genovis Inc)
    93
    Genovis Inc receiver operator characteristics curve auroc analysis
    Receiver Operator Characteristics Curve Auroc Analysis, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pm40593901-123-2-2?v=Genovis+Inc
    Average 93 stars, based on 1 article reviews
    receiver operator characteristics curve auroc analysis - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    liver fibrosis regression auroc analysis  (Omics Data Automation)
    86
    Omics Data Automation liver fibrosis regression auroc analysis
    Liver Fibrosis Regression Auroc Analysis, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pm41922110-263-6-15?v=Omics+Data+Automation
    Average 86 stars, based on 1 article reviews
    liver fibrosis regression auroc analysis - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    auroc analysis  (MedCalc Software Ltd)
    90
    MedCalc Software Ltd auroc analysis
    <t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
    Auroc Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pmc11795793-91-2-20?v=MedCalc+Software+Ltd
    Average 90 stars, based on 1 article reviews
    auroc analysis - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    analysis of the (auroc)  (MedCalc Software Ltd)
    90
    MedCalc Software Ltd analysis of the (auroc)
    <t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
    Analysis Of The (Auroc), supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pm37023561-84-7-11?v=MedCalc+Software+Ltd
    Average 90 stars, based on 1 article reviews
    analysis of the (auroc) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14  (STATA Corporation)
    99
    STATA Corporation auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14
    <t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
    Auroc Values 0 60 Were Considered Poorly Predictive 21 Statistical Analysis Was Performed Using Stata 14, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pm35419955-49-0-12?v=STATA+Corporation
    Average 99 stars, based on 1 article reviews
    auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    receiver operating characteristic analysis auroc  (MedCalc Software Ltd)
    90
    MedCalc Software Ltd receiver operating characteristic analysis auroc
    ROC analysis of the potential of ANRIL <t>and</t> <t>HOXA11-AS</t> to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL <t>(auROC=0.755;</t> 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.
    Receiver Operating Characteristic Analysis Auroc, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/pmc08713178-97-20-23?v=MedCalc+Software+Ltd
    Average 90 stars, based on 1 article reviews
    receiver operating characteristic analysis auroc - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    auroc curve analysis  (MedCalc Software Ltd)
    90
    MedCalc Software Ltd auroc curve analysis
    ROC analysis of the potential of ANRIL <t>and</t> <t>HOXA11-AS</t> to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL <t>(auROC=0.755;</t> 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.
    Auroc Curve Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/auroc+analysis/10__3171_slash_2018__1__jns171906-58-4-10?v=MedCalc+Software+Ltd
    Average 90 stars, based on 1 article reviews
    auroc curve analysis - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).

    Journal: Heliyon

    Article Title: Role of C5aR2 in prognosis of patients with acute respiratory distress syndrome through negative modulation of C5a: A prospective observational study

    doi: 10.1016/j.heliyon.2025.e42146

    Figure Lengend Snippet: Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).

    Article Snippet: Area under receiver operating characteristic (AUROC) was used to analyse the prognostic performance of C5a, C5R2, and C5a/C5R2 ratio using MedCalc.

    Techniques:

    ROC analysis of the potential of ANRIL and HOXA11-AS to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL (auROC=0.755; 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.

    Journal: Experimental and Therapeutic Medicine

    Article Title: Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis

    doi: 10.3892/etm.2021.11038

    Figure Lengend Snippet: ROC analysis of the potential of ANRIL and HOXA11-AS to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL (auROC=0.755; 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.

    Article Snippet: To assess differences in prognostic efficiency involving ANRIL and HOXA11-AS, the area under the curve of a receiver operating characteristic analysis (auROC) using MedCalc, which is a measure of discrimination, was calculated.

    Techniques: Expressing